A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2
Wagstaff et al., Pharmaceutics, doi:10.3390/pharmaceutics17091205
https://c19early.org/wagstaff4.html